In Vivo Assessment of Vesicular Monoamine Transporter Type 2 in Dementia With Lewy Bodies and Alzheimer Disease | Zendy

Victor L. Villemagne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vivo Assessment of Vesicular Monoamine Transporter Type 2 in Dementia With Lewy Bodies and Alzheimer Disease

Author(s) -

Victor L. Villemagne

Publication year - 2011

Publication title -

archives of neurology

Language(s) - English

Resource type - Journals

eISSN - 1538-3687

pISSN - 0003-9942

DOI - 10.1001/archneurol.2011.142

Subject(s) - dementia with lewy bodies , monoamine neurotransmitter , vesicular monoamine transporter , disease , alzheimer's disease , dementia , in vivo , neuroscience , medicine , biology , pathology , serotonin , genetics , receptor

To assess the diagnostic potential of imaging striatal monoaminergic terminal integrity with the vesicular monoamine transporter type 2 (VMAT2) radioligand (18)F 9-fluropropyl-(+)-dihydrotetrabenazine ([(18)F]AV-133) and positron emission tomography to distinguish dementia with Lewy bodies (DLB) from Alzheimer disease (AD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research